Search

everythinglearnresearchcommunity

for

Search:↓

The method can test hair growth products using a lab-made hair-like structure that responds to known treatments.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

The FUE technique can effectively restore moustaches in patients with cleft lips and alopecia, with few complications.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

A new version of minoxidil, a hair loss treatment, was made using nanotechnology. This version, called minoxidil cubosomes, works better and causes fewer skin reactions than the old version. It also penetrates and stays in the skin better, promoting hair regrowth. It's safe and could be a good alternative to current treatments.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Nutritional supplements may help improve hair growth in female pattern hair loss.

Minoxidil alone is the most cost-effective treatment for male hair loss at a $50,000 threshold.

Women are more likely to have long-term post-COVID symptoms than men.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Shift work disrupts the body's natural clock, leading to health problems.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Stress might contribute to hair loss in alopecia areata.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Stress hormones and autoimmune reactions can cause hair loss.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Non-coding RNAs could help detect and treat radiation damage.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Special particles from skin cells can promote hair growth by activating a specific growth signal.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.